Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,100Open textbooks2Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology107Genetics and Genomics95Neuroscience110Cardiovascular Medicine105Immunology90Pharmacology99Molecular Biology100Infectious Diseases102Rare and Inherited Diseases106Clinical Research98Anatomy and Physiology542Drugs and Chemicals546
Plans & pricingCompare EvidenceHelix workspace plans
Library›EvidenceLib›Drugs and Chemicals›Acetates
Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Research reading room

Acetates

Drugs and Chemicals · NLM MeSH · updated 2026-10-31 · version 1

Citations verified against PubMedNot yet clinician-reviewed10 referencesApproximately 3 min read

Derivatives of acetic acid.

Table of Contents

1. Definition2. Research landscape3. Reading the evidence4. Open-access studies5. Key reviews6. References7. About this article

Definition and research guide

This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.

Content available: 4 complete abstracts (574 words), 10 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.

Definition

Derivatives of acetic acid. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxymethane structure.

Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.

Also known as: Acetate; Acetic Acid Esters; Esters, Acetic Acid; Acetic Acids; Acids, Acetic.

Where it fits in the MeSH classification

Broader topics
Acids, Acyclic; Fatty Acids, Volatile
Narrower topics
Acetamides; Acetic Acid; Acetic Anhydrides; Aminooxyacetic Acid; Chloroacetates; Edetic Acid; Egtazic Acid; Fluoroacetates; Glycolates; Iodoacetates; Nitrilotriacetic Acid; Pentetic Acid; Peracetic Acid; Phosphonoacetic Acid

Related concepts

  • Acetic Acid

Research landscape

PubMed indexes 166,705 records tagged with the MeSH heading “Acetates” (counts retrieved 2026-10-31). 18,669 of them (11.2%) were published from 2020 onward, and the busiest period so far is through 1999 with 83,248 records.

Reviews account for 6,179 records (3.7%) and meta-analyses for 509. Randomized controlled trials number 3,327 (2.0%) as a share of all records on the topic. Randomized trials make up only a small share of this literature, so much of what is known comes from laboratory, observational or descriptive work.

PubMed records by publication periodthrough 1999: 83,248 records; 2000-2009: 31,873 records; 2010-2019: 32,915 records; 2020 onward: 18,669 records83,248through 199931,8732000-200932,9152010-201918,6692020 onward
Records in PubMed indexed with this heading, by publication period. Real counts from NCBI E-utilities; the final period covers only part of the current year. Volume reflects how much has been published, not how strong the evidence is.
Show the data
PeriodRecords
through 199983,248
2000-200931,873
2010-201932,915
2020 onward18,669
Share of records by publication typeReviews: 3.7 percent; Meta-analyses: 0.3 percent; Randomized controlled trials: 2.0 percentReviews3.7% (6,179)Meta-analyses0.3% (509)Randomized controlled trials2.0% (3,327)
Share of all PubMed records on this heading that carry each publication type. Types overlap with other records, so the shares do not sum to 100%.
Publication-type chart data
Publication types among 166,705 PubMed records
TypeRecordsShare
Reviews6,1793.7%
Meta-analyses5090.3%
Randomized controlled trials3,3272.0%

Method: PubMed query "Acetates"[MeSH Terms] with publication-type and date filters, retrieved 2026-10-31.

Reading the evidence in drugs and chemicals

Studies of a chemical or drug can answer very different questions: what it is and how it behaves in cells and animals, how the body handles it, and whether it changes outcomes in people. Laboratory and animal findings often do not carry over to patients, and observational studies of exposures are confounded by who uses a substance and why. Nothing on this page is a recommendation to use, avoid, start or stop any substance or medicine; talk to a qualified clinician or pharmacist about your own situation. Check the dose, the species, the comparison group and whether a patient-relevant outcome was measured.

Evidence from open-access studies

These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.

Study comparison — selected abstracts, not a systematic review
Study / authorsYearSource label / designEurope PMC citationsLicence / source
Ongoing independent evolution of linezolid and vancomycin-resistance pELF-type linear plasmids across the One Health spectrum
Hashimoto Y, Dao DT, Kasuga I, Takemura T, Abe H, Hasebe F, et al.
2025Research article
Design not recorded in structured metadata
8cc by
PMID 41251365 · DOI · PMC12691693
Metabolic versatility enables acetogens to colonize ruminants with diet-driven niche partitioning
Li Q, Wang R, Zhou X, Li S, Zhang S, Zhang X, et al.
2025Research article
Design not recorded in structured metadata
6cc by
PMID 40888465 · DOI · PMC12449052
Advances in the therapeutic applications of dichloroacetate as a metabolic regulator: A review
Wu X, Shang M, Li M, Liu Y, Hu H, Zhang P, et al.
2025Review article
Design not recorded in structured metadata
6cc by
PMID 40922281 · DOI · PMC12419407
Efficacy of a foamed disinfectant in reducing pathogen contamination in renovated inpatient in-room sinks: a randomized controlled trial
Warren BG, Graves AM, Fils-Aime G, Barrett A, Mamikunian I, Gunsch C, et al.
2026Randomized controlled trial
Design not recorded in structured metadata
5cc by
PMID 41085344 · DOI · PMC12780837

Ongoing independent evolution of linezolid and vancomycin-resistance pELF-type linear plasmids across the One Health spectrum [1]

Research article Hashimoto Y, Dao DT, Kasuga I, Takemura T, Abe H, Hasebe F, et al. · · 2025 · cited 8 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Vancomycin and linezolid are crucial for treating enterococcal infections.
Closing excerpt
Our findings on this ongoing evolution advance the fundamental knowledge required for the future development of global and cross-sectoral surveillance.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (84 words)

Vancomycin and linezolid are crucial for treating enterococcal infections. The global emergence of linezolid- and vancomycin-resistant enterococci is a growing concern. Enterococcal pELF-type linear plasmids, which confer both types of resistance, have been identified worldwide from clinical and environmental sources. Phylogenetic and structural analyses of pELF-type linear plasmids revealed that they diverged into two distinct lineages and evolved through the integration of circular plasmids. Our findings on this ongoing evolution advance the fundamental knowledge required for the future development of global and cross-sectoral surveillance.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 41251365 · DOI · PMC12691693

Metabolic versatility enables acetogens to colonize ruminants with diet-driven niche partitioning [2]

Research article Li Q, Wang R, Zhou X, Li S, Zhang S, Zhang X, et al. · · 2025 · cited 6 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Enteric methane emissions are energy losses from farmed ruminants and contribute to global warming.
Closing excerpt
Overall, this study highlights the overlooked heterotrophy of acetogens in the rumen and their potential for mitigating enteric methane emissions.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (177 words)

Enteric methane emissions are energy losses from farmed ruminants and contribute to global warming. Diverting electrons and H2 flow toward beneficial fermentation products would mitigate ruminal methane emissions while improving feed efficiency. Acetogens can direct H2 and electrons to acetate production via the Wood-Ljungdahl pathway, but methanogens have more competitive H2 affinities. Thus, it is unclear how acetogenesis contributes to the rumen fermentation. An analysis of 2102 globally derived rumen metagenomes from multiple ruminant species revealed that putative acetogens were phylogenetically diverse and capable of using carbohydrates or H2 as electron donors. The metabolic versatility of these acetogens may enable them to outcompete methanogens with lower versatility. Through animal trials, in vitro experiments, and DNA stable isotope probing, we verified the presence of diverse acetogens in beef cattle rumens and revealed that their niche partitioning is driven by contrasting fiber-rich and starch-rich diets. A fiber-rich diet enriched heterotrophic acetogens, which increased acetate formation while decreasing methane production. Overall, this study highlights the overlooked heterotrophy of acetogens in the rumen and their potential for mitigating enteric methane emissions.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 40888465 · DOI · PMC12449052

Advances in the therapeutic applications of dichloroacetate as a metabolic regulator: A review [3]

Review article Wu X, Shang M, Li M, Liu Y, Hu H, Zhang P, et al. · · 2025 · cited 6 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Dichloroacetate (DCA), as a pan-inhibitor of pyruvate dehydrogenase kinase, plays a crucial role in energy metabolism and mitochondrial function.
Closing excerpt
In this review, we summarize advances in the therapeutic applications of DCA as a metabolic regulator.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (100 words)

Dichloroacetate (DCA), as a pan-inhibitor of pyruvate dehydrogenase kinase, plays a crucial role in energy metabolism and mitochondrial function. DCA decreases lactic acid synthesis, enhances mitochondrial oxidative phosphorylation, and regulates aerobic glycolysis. During the last decade, more and more studies have found that disorders of energy metabolism and mitochondrial dysfunction play a pivotal role in the development and progression of various diseases, and the role of DCA in cancer, metabolic diseases, and inflammatory diseases has been extensively explored in both basic and clinical studies. In this review, we summarize advances in the therapeutic applications of DCA as a metabolic regulator.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 40922281 · DOI · PMC12419407

Efficacy of a foamed disinfectant in reducing pathogen contamination in renovated inpatient in-room sinks: a randomized controlled trial [4]

Randomized controlled trial Warren BG, Graves AM, Fils-Aime G, Barrett A, Mamikunian I, Gunsch C, et al. · · 2026 · cited 5 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
BackgroundHospital sinks are reservoirs for epidemiologically important pathogens (EIPs), yet practical, effective strategies for sustained decontamination are lacking.
Closing excerpt
Foam-based protocols may help mitigate environmental reservoirs of multidrug-resistant organisms.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (213 words)

BackgroundHospital sinks are reservoirs for epidemiologically important pathogens (EIPs), yet practical, effective strategies for sustained decontamination are lacking.MethodsWe conducted a randomized controlled trial of 30 in-room sinks (15 intervention, 15 control) in a newly renovated hospital unit to evaluate the efficacy of a hydrogen peroxide/peracetic acid foamed disinfectant in reducing sink contamination. Intervention sinks received foamed disinfectant to sink drains three times weekly; control sinks underwent standard daily surface cleaning. Weekly sampling was performed from three sink locations (top surface, tail pipe, P-trap) over 35 weeks. The primary outcome was sink conversion events (SCEs), defined as first detection of ≥1 EIP, defined as Pseudomonas aeruginosa, Stenotrophomonas spp., or Acinetobacter spp., and ESBL-producing or carbapenem-resistant Enterobacterales, in previously negative sinks.ResultsA total of 2880 samples were collected. All sinks were negative at baseline for study pathogens. Nearly all sinks (29/30) experienced an SCE during the study period. However, only 44 (9%) intervention sink samples were positive for EIPs, compared to 270 (47%) in control sinks (p Acinetobacter spp. and Stenotrophomonas spp. Intervention sinks experienced a delayed time to SCE (p = 0.0001). Items were stored on/in sinks in 93% of observations.ConclusionRegular application of a foamed disinfectant reduced and delayed EIP contamination in renovated hospital sinks. Foam-based protocols may help mitigate environmental reservoirs of multidrug-resistant organisms.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 41085344 · DOI · PMC12780837

Key reviews and meta-analyses

The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.

  • Research article Molecular Glues for Targeted Protein Degradation: From Serendipity to Rational Discovery [5]
    Dong G, Ding Y, He S, Sheng C · J Med Chem · 2021 · cited 293 times (Europe PMC)
  • Research article Impact of 68Ga-PSMA PET on the Management of Patients with Prostate Cancer: A Systematic Review and Meta-analysis [6]
    Han S, Woo S, Kim YJ, Suh CH · Eur Urol · 2018 · cited 253 times (Europe PMC)
  • Research article 68Ga-DOTATATE Compared with 111In-DTPA-Octreotide and Conventional Imaging for Pulmonary and Gastroenteropancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis [7]
    Deppen SA, Blume J, Bobbey AJ, Shah C, Graham MM, Lee P, et al. · J Nucl Med · 2016 · cited 178 times (Europe PMC)
  • Research article Systematic review and meta-analysis of linezolid versus daptomycin for treatment of vancomycin-resistant enterococcal bacteremia [8]
    Balli EP, Venetis CA, Miyakis S · Antimicrob Agents Chemother · 2014 · cited 118 times (Europe PMC)
  • Research article Antidepressant efficacy of agomelatine: meta-analysis of published and unpublished studies [9]
    Taylor D, Sparshatt A, Varma S, Olofinjana O · BMJ · 2014 · cited 111 times (Europe PMC)
  • Research article The Global Threat from the Irreversible Accumulation of Trifluoroacetic Acid (TFA) [10]
    Arp HPH, Gredelj A, Glüge J, Scheringer M, Cousins IT · Environ Sci Technol · 2024 · cited 108 times (Europe PMC)

References

  1. Hashimoto Y, Dao DT, Kasuga I, Takemura T, Abe H, Hasebe F, et al.. Ongoing independent evolution of linezolid and vancomycin-resistance pELF-type linear plasmids across the One Health spectrum. . 2025. PMID 41251365 · DOI · PMC12691693
  2. Li Q, Wang R, Zhou X, Li S, Zhang S, Zhang X, et al.. Metabolic versatility enables acetogens to colonize ruminants with diet-driven niche partitioning. . 2025. PMID 40888465 · DOI · PMC12449052
  3. Wu X, Shang M, Li M, Liu Y, Hu H, Zhang P, et al.. Advances in the therapeutic applications of dichloroacetate as a metabolic regulator: A review. . 2025. PMID 40922281 · DOI · PMC12419407
  4. Warren BG, Graves AM, Fils-Aime G, Barrett A, Mamikunian I, Gunsch C, et al.. Efficacy of a foamed disinfectant in reducing pathogen contamination in renovated inpatient in-room sinks: a randomized controlled trial. . 2026. PMID 41085344 · DOI · PMC12780837
  5. Dong G, Ding Y, He S, Sheng C. Molecular Glues for Targeted Protein Degradation: From Serendipity to Rational Discovery. J Med Chem. 2021. PMID 34319094 · DOI
  6. Han S, Woo S, Kim YJ, Suh CH. Impact of 68Ga-PSMA PET on the Management of Patients with Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol. 2018. PMID 29678358 · DOI
  7. Deppen SA, Blume J, Bobbey AJ, Shah C, Graham MM, Lee P, et al.. 68Ga-DOTATATE Compared with 111In-DTPA-Octreotide and Conventional Imaging for Pulmonary and Gastroenteropancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis. J Nucl Med. 2016. PMID 26769864 · DOI · PMC5362941
  8. Balli EP, Venetis CA, Miyakis S. Systematic review and meta-analysis of linezolid versus daptomycin for treatment of vancomycin-resistant enterococcal bacteremia. Antimicrob Agents Chemother. 2014. PMID 24247127 · DOI · PMC3910884
  9. Taylor D, Sparshatt A, Varma S, Olofinjana O. Antidepressant efficacy of agomelatine: meta-analysis of published and unpublished studies. BMJ. 2014. PMID 24647162 · DOI · PMC3959623
  10. Arp HPH, Gredelj A, Glüge J, Scheringer M, Cousins IT. The Global Threat from the Irreversible Accumulation of Trifluoroacetic Acid (TFA). Environ Sci Technol. 2024. PMID 39475534 · DOI · PMC11562725

About this article

Sources
NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
Verification
Every reference was resolved against PubMed on 2026-10-31; title, year and DOI matched.
Review state
automated source verified; no human expert review has been recorded yet.
Version
1, last updated 2026-10-31.

See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.

Evidence strength

EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.

Included with the Researcher plan

Reading every article stays free. This computed view is part of the paid plans.

See plans Sign in

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.

Related research topics

  • Acetic AcidDrugs and Chemicals
  • Valproic AcidDrugs and Chemicals
  • Butyric AcidDrugs and Chemicals
  • N-Acetylneuraminic AcidDrugs and Chemicals
  • Sialic AcidsDrugs and Chemicals
  • Mycophenolic AcidDrugs and Chemicals

All 546 articles in Drugs and Chemicals →

At a glance

166,705
PubMed records on this heading
11%
published since 2020
6,179
review articles
3,327
randomized trials
10
verified references below

Counts come from PubMed on 2026-10-31; they show how much has been written, not how strong the evidence is.

Related topics See all →

  • Acetic AcidDrugs and Chemicals
  • Valproic AcidDrugs and Chemicals
  • Butyric AcidDrugs and Chemicals
  • N-Acetylneuraminic AcidDrugs and Chemicals
  • Sialic AcidsDrugs and Chemicals

My notes & annotations (0)

Nothing yet. Select text and press Highlight, or write a note in the Notes tab. Stored in this browser only.

Sources

  • NLM MeSH record ↗
  • PubMed search used ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Legal · Support